Dr. Jacqueline E. Feinberg, MD

Dr. Feinberg practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Feinberg's NPI, 1508245549, was assigned on May 22, 2015. Dr. Feinberg graduated from Rutgers Robert Wood Johnson Medical School in 2015. Dr. Feinberg holds New Jersey license 25MA11924300.

Dr. Feinberg's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Feinberg's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Feinberg to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feinberg practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Feinberg's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Feinberg is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Feinberg's licenses on file in 3 states: New Jersey, New York and Connecticut.

CMS data shows 143 Medicare services from Dr. Feinberg across 5 procedure codes in 2024, all of them office visits, for 82 Medicare patients. Medicare paid $10,891 for them. Every service was in an office.

CMS counts 82 Medicare patients who saw Dr. Feinberg in 2024. The largest group is 75 to 84, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feinberg's median patient age at 69, with 98% women.

In 2024, Dr. Feinberg wrote 45 Medicare Part D claims for 19 patients. 98% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $88 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Feinberg for performance year 2024, reported as part of a group. Dr. Feinberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feinberg as offering telehealth. CMS counts 36 procedures of removal of the uterus by Dr. Feinberg, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Feinberg, published from 2010 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Ovarian Neoplasms, Postoperative Complications and Endometrial Neoplasms. Dr. Feinberg has published most often in Int J Gynecol Cancer. Dr. Feinberg's most frequent co-authors are Nadeem R. Abu-Rustum, MD, Mario Mendes Leitao, MD and Dennis S. Chi, MD.

CMS Open Payments shows 6 general payments to Dr. Feinberg from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $303.

Dr. Feinberg graduated from Rutgers Robert Wood Johnson Medical School in 2015.

Dr. Feinberg is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.